71% of Cancer Patients Report Unmet Rehabilitation Needs Despite Clinic Access
Cancer survival rates have improved dramatically over recent decades, yet the conversation about what survival actually looks like for patients—physically…
Found 1715 results for "cancer"
Cancer survival rates have improved dramatically over recent decades, yet the conversation about what survival actually looks like for patients—physically…
For adults navigating pancreatic disease, liver conditions, or gastrointestinal cancers, the tools physicians use to detect and characterize disease are…
For every individual who suspects a hereditary cancer risk, there are likely many more carrying actionable germline variants who were never referred for…
For the millions of adults who routinely consume zero-calorie sweeteners while managing weight or blood sugar, the assumption that sucralose is biologically…
Two of oncology's most formidable diagnoses may be entering a new era — not through a single breakthrough, but through the convergence of molecular profiling…
For decades, roughly 80% of disease-causing proteins have been considered undruggable because conventional small molecules cannot block them effectively. A…
For the millions living with ischaemic heart failure, cardiac fibrosis — the progressive stiffening of heart tissue — remains one of the most difficult…
Cancer immunotherapy's next frontier may lie not in checkpoint inhibitors, but in the molecular scaffolding that suppresses immune cells from within tumors…
Epigenetic therapies for cancer have long struggled with a fundamental limitation: the DNA-methylation machinery is partially shielded by cellular…
For the millions of families navigating rare accelerated-aging disorders in children, identifying molecular rescue pathways offers a rare window of hope. New…
Understanding how cells physically move through tissue has implications far beyond basic biology — it sits at the intersection of wound healing, embryonic…
Solid tumors routinely outgrow their blood supply, creating oxygen-starved cores where most therapies lose potency. Understanding the molecular machinery that…
Antifungal resistance is quietly becoming one of medicine's most urgent unsolved problems, with immunocompromised patients — cancer survivors, transplant…
Most people assume that if a chemical passes standard toxicity screening, its biological risks are well characterized. That assumption is now seriously…
For the roughly 250,000 people worldwide living with achondroplasia — the most common form of dwarfism — treatment options have historically been limited to…
When a rare childhood cancer responds to a drug designed for a completely different tumor type, it reframes how oncologists should think about molecular…
For patients with aggressive blood cancers once considered incurable after relapse, the question of whether cellular immunotherapy delivers lasting benefit—or…
Stomach cancer remains one of the more preventable yet underdiagnosed malignancies in the Western world, largely because its early symptoms mimic common…
When we think about the pillars of a long life, urology rarely tops the list — yet conditions managed by urologists, from prostate disease to kidney disorders…
Adults who survived childhood cancer already carry an elevated biological age relative to their chronological years, but a critical mechanism driving that gap…